Cargando…

Conference Report: European Society for Medical Oncology Congress 2022

The European Society of Medical Oncology took place in Paris Convention Centre, Paris, France on 9th −13th September 2022 and was attended by more than 28,000 delegates, 23,000 of which were in person and 5000 online. This was the first on-site ESMO congress after the COVID-19 pandemic. This report...

Descripción completa

Detalles Bibliográficos
Autor principal: Dogan, Sevda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989427/
https://www.ncbi.nlm.nih.gov/pubmed/36895524
http://dx.doi.org/10.1177/20363613231162474
_version_ 1784901764533714944
author Dogan, Sevda
author_facet Dogan, Sevda
author_sort Dogan, Sevda
collection PubMed
description The European Society of Medical Oncology took place in Paris Convention Centre, Paris, France on 9th −13th September 2022 and was attended by more than 28,000 delegates, 23,000 of which were in person and 5000 online. This was the first on-site ESMO congress after the COVID-19 pandemic. This report focuses on a selection of talks delivered at the conference. There was a vast collection of interesting talks, nevertheless, I attended talks that focused on rare cancers.
format Online
Article
Text
id pubmed-9989427
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-99894272023-03-08 Conference Report: European Society for Medical Oncology Congress 2022 Dogan, Sevda Rare Tumors Editorial The European Society of Medical Oncology took place in Paris Convention Centre, Paris, France on 9th −13th September 2022 and was attended by more than 28,000 delegates, 23,000 of which were in person and 5000 online. This was the first on-site ESMO congress after the COVID-19 pandemic. This report focuses on a selection of talks delivered at the conference. There was a vast collection of interesting talks, nevertheless, I attended talks that focused on rare cancers. SAGE Publications 2023-03-03 /pmc/articles/PMC9989427/ /pubmed/36895524 http://dx.doi.org/10.1177/20363613231162474 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Editorial
Dogan, Sevda
Conference Report: European Society for Medical Oncology Congress 2022
title Conference Report: European Society for Medical Oncology Congress 2022
title_full Conference Report: European Society for Medical Oncology Congress 2022
title_fullStr Conference Report: European Society for Medical Oncology Congress 2022
title_full_unstemmed Conference Report: European Society for Medical Oncology Congress 2022
title_short Conference Report: European Society for Medical Oncology Congress 2022
title_sort conference report: european society for medical oncology congress 2022
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989427/
https://www.ncbi.nlm.nih.gov/pubmed/36895524
http://dx.doi.org/10.1177/20363613231162474
work_keys_str_mv AT dogansevda conferencereporteuropeansocietyformedicaloncologycongress2022